AI assistant
ANSELL LIMITED — Capital/Financing Update 2013
Dec 22, 2013
64385_rns_2013-12-22_0938d65c-f322-4747-b927-83fd306d9e47.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
PRESS RELEASE
==> picture [103 x 32] intentionally omitted <==
For Immediate Release 23 December 2013 Not for release in the United States
For more information: Ansell Limited A.C.N. 004 085 330 Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia GPO Box 772H, Melbourne, Victoria 3001, Australia Telephone (+61 3) 9270 7270 Facsimile (+61 3) 9270 7300 [email protected]
SUCCESSFUL COMPLETION OF ANSELL LIMITED'S SHARE PURCHASE PLAN
Ansell Limited (ASX:ANN) (Ansell) is pleased to announce the successful completion of its share purchase plan (SPP).
Ansell has accepted applications for approximately A$72 million of new shares from Eligible Shareholders. Valid applications have been accepted in full with no scale back. Ansell will issue approximately 3.9 million shares at $18.50 per share.
Ansell's Chief Financial Officer, Mr Neil Salmon, said, "We are pleased that many of our Australian and New Zealand shareholders elected to participate in the SPP and are purchasing up to $15,000 worth of shares at the same price offered to institutional investors in the placement that was announced on 26 November 2013. Approximately 19% of shareholders applied for shares under the SPP, and will be issued shares at a discount to the current Ansell share price."
As previously announced to ASX, a portion of the proceeds from the SPP will be used to fund the acquisition of BarrierSafe Solutions International, with additional capital available to support group liquidity and growth initiatives.
The SPP was announced on 26 November 2013. The SPP offer opened on 4 December 2013 and closed on 18 December 2013. Quotation of new shares issued under SPP on ASX is expected on 31 December 2013.
For information on the SPP please call the Ansell SPP Offer Information Line between 8.30am and 5.30pm Monday to Friday on 1300 850 505 (from within Australia) or +61 3 9415 4000 (outside Australia).
For further enquiries, please contact:
| Investors and Analysts | |||
|---|---|---|---|
| Australia: | David Graham, I.R. | Tel: (+613) 9270 7215 | [email protected] |
| Media | |||
| Australia: | Helen McCombie, Citadel | Tel: (614)11 756 248 | [email protected] |
| Peter Bookes, Citadel | Tel: (614)07 911 389 | [email protected] |
About the Placement and SPP
Further information in relation to the specific details of the Placement and SPP described in this announcement including important notices and key risks in relation to certain forward looking information is set out in an investor presentation released on 26 November 2013 by Ansell. The information in the ‘Important Notice and Disclaimer’ and ‘Key Risks’ sections of the investor presentation applies to this announcement as if set out in full in this announcement. This press release includes “forward looking statements” within the meaning of securities laws of applicable jurisdictions. Forward looking statements can generally be identified by the use of the words “anticipate”, “believe”, “expect”, “project”, “forecast”, “estimate”, “likely”, “intend”, “should”, “could”, “may”, “target”, “plan” “guidance” and other
similar expressions. Indications of, and guidance on, future earning or distributions and financial position and performance are also forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Ansell, and its officers, employees, agents or associates, that may cause actual results to differ materially from those expressed or implied in such statement. Actual results, performance or achievements may vary materially from any projections and forward looking statements and the assumptions on which those statements are based. Readers are cautioned not to place undue reliance on forward looking statements and Ansell assumes no obligation to update such information.
Important Notice
This announcement has been prepared for publication in Australia and may not be released in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. The securities offered and sold in the Placement have not been, and will not be, registered under the U.S. Securities Act of 1933 (“US Securities Act”) and may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the US Securities Act and applicable US state securities laws. The securities to be offered and sold in the SPP will only be offered and sold to eligible shareholders in Australia and New Zealand in offshore transactions in reliance on Regulation S under the US Securities Act.
About Ansell
Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being.
With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 13,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical Solutions, Industrial Solutions, Specialty Markets and Sexual Wellness.
Information on Ansell and its products can be found at www.ansell.com.
==> picture [53 x 20] intentionally omitted <==
==> picture [35 x 21] intentionally omitted <==
==> picture [61 x 13] intentionally omitted <==
==> picture [37 x 12] intentionally omitted <==
® are trademarks owned by Ansell Limited or one of its affiliates. © 2013 Ansell Limited. All Rights Reserved.
2